Surgipharm Kenya Limited, KES1 billion, MLA and Sole Lender

Oct 31, 2018

Stanbic Bank Kenya was the mandated lead arranger for a KES1 billion term loan to Surgipharm Limited, Kenya. This facility was meant to refinance existing shareholder debt, with Standard Bank Kenya being the sole lender.

Surgipharm had an outstanding shareholder debt that was to be immediately cleared due to the acquisition of 70% stake by Imperial Holdings in 2017. Imperial Holdings has a presence in 31 countries globally.

Headquartered in Nairobi, Surgipharm is a leading distributor of pharmaceutical, medical, surgical and allied supplies in Kenya with an annual turnover of approximately USD70 million.

The business caters for the needs of all pharmaceutical distribution channels in the country, directly supplying products to the Ministry of Health, parastatals, NGOs, hospitals, clinics, dispensing doctors, pharmacies and wholesalers.

This transaction demonstrates financial and business support to the primary pharmaceutical sectors in addition to supporting regional networks with their expansion plans.

Back to all deals
  • Share
  • Email
Get in touch with us

Connect with the right client relationship and specialist teams to move you forward.


Bringing you the latest insights from the Standard Bank Group


Subscribe to our quarterly newsletter
giving you our latest insights